About Oncobiomix
Oncobiomix is a private company based in San Antonio, Texas, incorporated in 2023 in Delaware. It has reported $600,000 raised in two offerings on Form D since November 2023. Its chief executive is Michael Liss.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 16, 2026 | $100,000of $2.5M target | 1 | $100K | OptionsRule 506(b) | Form D ↗ |
| Oct 26, 2023 | Nov 6, 2023amended Sep 2, 2025 | $500,000of $1.0M target | 12 | $41,667 | Convertible DebtRule 506(b) | Form D/A ↗3 earlier filings |
| Total, two offerings | $600,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Oncobiomix's Form D filed Sep 16, 2026.
